• 
• 
• 
• 
• 

FDA News and Drug Updates

Cancer Drug Approvals: A Tale of 2 Views

Rucaparib Approved with a Companion Diagnostic Test for Patients with Advanced Ovarian Cancer

FDA Approves Rucaparib and Companion Diagnostic for Patients with Advanced Ovarian Cancer

Daratumumab Combination Approved for Multiple Myeloma

Supportive Care

A Taxing Consequence: Taxane Acute Pain Syndrome

Mark L. Zangardi, PharmD, BCOP

Helping Adolescents and Young Adults Confront Mortality

Meg Barbor, MPH

The Emerging Conversation About Physician-Assisted Death

Meg Barbor, MPH

View All Supportive Care Articles

Breast Cancer

Abemaciclib Improves Progression-Free Survival by 7 Months in Women with Metastatic Breast Cancer

Pembrolizumab Substantially Improves Response Rates in Patients with High-Risk Breast Cancer

PARP Inhibitor Improves Outcomes in BRCA-Mutated Breast Cancer

View All Breast Cancer Articles

Conference Correspondent

Overcoming Cultural Barriers to Screening Access

AONN+ Regional Meeting Addresses the Rapidly Evolving Role of the Navigator

Tackling Obesity and Excess Weight in Patients with Cancer

View All Conference Correspondent Articles

Most Popular Articles

Chemotherapy Discharge Education Class Improves Patient Safety

Alice Goodman

TON - July 2017, Vol 10, No 4 - Best Practices

Nurse Navigation Program Improves Access and Satisfaction with Cancer Care

Alice Goodman

TON - July 2017, Vol 10, No 4 - Best Practices

Survivorship Care Evolves with Fine-Tuning

Phoebe Starr

TON - July 2017, Vol 10, No 4 - Survivorship

Enzalutamide in the Treatment of Patients with Metastatic Castrate-Resistant Prostate Cancer

Adegoke O. Adeniji, BPharm, PhD, David A. Kaland, PhD, Launa M.J. Lynch, PhD, Vicky M. Mody, PhD

JHOP Web Exclusives - Online First, Review Article